United States Radiofrequency Ablation Devices Market generated revenue of US$ 1,172.6 million in 2022 and is projected to attain a market size of US$ 2,977.8 million by 2031, growing at a CAGR of 11.24% during the forecast period from 2023 to 2031.
The United States radiofrequency ablation devices market is expected to experience significant growth in the upcoming years. This growth can be due to the rising occurrence of chronic conditions and chronic pain, as well as the advantages that radiofrequency ablation (RFA) provides compared to other treatment options. Furthermore, the increasing popularity of minimally invasive procedures presents promising opportunities for market expansion. Radiofrequency ablation devices are primarily utilized in the field of surgical oncology.
A Request of this Sample Report Here- https://www.astuteanalytica.com/request-sample/united-states-radiofrequency-ablation-devices-market
By the end of 2023, there will be 1,958,310 new cases of cancer and 609,820 cancer-related deaths in the United States. Prostate cancer, which had been experiencing a decline for two decades, saw a 3% annual increase in incidence from 2014 to 2019, resulting in an additional 99,000 new cases. This rise in cancer cases highlights the urgent need for effective treatments. Radiofrequency ablation, known for its precision and efficiency, is emerging as a promising solution in the field of surgical oncology, contributing to the growing demand for this technology. As a result, surgical oncology is likely to capture a significant revenue share of over 45% by the year 2031, solidifying its dominance in the market.
The increasing prevalence of chronic pain is a major factor driving the radiofrequency ablation devices market in the United States. According to a study conducted by the National Institutes of Health, the incidence of new cases of chronic pain is higher among U.S. adults compared to several other common conditions, such as diabetes, depression, and high blood pressure. Approximately 21% of adults experience chronic pain, while 8% experience high-impact chronic pain (HICP). The rate of new chronic pain cases is also significant, at 52.4 cases per 1,000 persons per year, surpassing the rates of new cases for diabetes (7.1 cases/1,000 per year), depression (15.9 cases/1,000 per year), and hypertension (45.3 cases/1,000 per year). This is noteworthy because chronic conditions often require prolonged and repetitive treatments, where radiofrequency ablation (RFA) devices play a crucial role due to their minimally invasive nature.
Emerging New Technologies: A Trend to Watch
Technological advancements play a crucial role in driving the trend of the radiofrequency ablation devices market. Over the past decade, several new technologies have emerged as researchers deepen their understanding of how cells respond to different energy stimuli and develop improved methods to control and direct ablation energies. Simultaneously, users of these devices are pushing for greater control and selectivity to minimize collateral damage during treatments.
According to a report by Astute Analytica, the radiofrequency ablation devices market in the United States is experiencing significant investments in medical device technologies, with an annual growth rate of 6%. This has led to an estimated $34 billion being spent on research and development in the field of medical technology in 2021. One notable advancement in this market is the integration of 3D mapping systems with radiofrequency ablation (RFA) devices.
This technology allows for a three-dimensional visualization of the area being treated, ensuring precise and accurate targeting. Hospitals that have adopted 3D mapping in conjunction with RFA have seen a 15% reduction in procedure time, leading to improved efficiency and patient throughput. By leveraging this technology, healthcare providers can enhance the effectiveness of RFA procedures.
The U.S. radiofrequency ablation devices market is witnessing substantial investments in medical device technologies, with the integration of 3D mapping systems being a notable advancement. This technology offers enhanced precision and efficiency in RFA procedures, leading to improved patient outcomes and increased operational efficiency for healthcare providers.
Hospitals are the Primary End-Users of Radiofrequency Ablation
According to market analysis by Astute Analytica, hospitals are the primary end users driving the growth of the radiofrequency ablation devices market in the United States. By the end of 2031, hospitals will account for a significant revenue share, exceeding 46%. This can be owing to the complex nature of ablation treatments, which require specialized staff and equipment available in hospital settings. The presence of these resources ensures safer and more effective procedures, contributing to the dominance of hospitals in the market.
For The Full Report, Please Follow This Link- https://www.astuteanalytica.com/industry-report/united-states-radiofrequency-ablation-devices-market
In the radiofrequency ablation devices market, hospitals play a crucial role, particularly for patients with concomitant conditions and the elderly who may not be suitable candidates for outpatient procedures. This trend indicates that hospitals not only maintain their leadership position in the market but are also expected to experience the fastest growth, with a projected compound annual growth rate (CAGR) of 11.70%. The strong demand for experienced operators and the need for specialized care during ablation treatments, which are more readily available in hospital settings, contribute to this anticipated growth.
Top Players in the US Radiofrequency Ablation Devices Market
- Baylis Medical
- Boston Scientific Corporation
- Bramsys Indústria e ComércioLtda
- C. R. Bard
- Cosman Medical, Inc.
- ENDO-FLEX GmbH
- Epimed International
- Halyard Health
- Inomed Medizintechnik GmbH
- Johnson & Johnson
- SFM Medical Devices GmbH
- Smith & Nephew
- St. Jude Medical
- Sutter Medizintechnik GmbH
- Other Prominent Players
Market Segmentation Overview:
By Device Type
- Capital Device
- Disposable Equipment
- Surgical Oncology
- Cardiology & Cardiac Rhythm Management
- Pain Management
By End User
- Ambulatory Surgical Centers
Get a Free Sample Report Here- https://www.astuteanalytica.com/request-sample/united-states-radiofrequency-ablation-devices-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬
𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫: +𝟏𝟖𝟖𝟖𝟒𝟐𝟗𝟔𝟕𝟓𝟕
𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/